Jump to content

Category:Andrew Schieber of Laguna Niguel CA (US)

From WikiTrademarks

Andrew Schieber of Laguna Niguel CA (US)

Executive Summary

Andrew Schieber of Laguna Niguel CA (US) is an inventor who has filed 1 patents. Their primary areas of innovation include {Introducing ophthalmic products into the ocular cavity or retaining products therein (putting in contact lenses (1 patents), Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations (1 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (1 patents), and they have worked with companies such as The Regents of the University of Colorado, a body Corporate (1 patents). Their most frequent collaborators include (1 collaborations), (1 collaborations).

Patent Filing Activity

File:Andrew Schieber of Laguna Niguel CA (US) Monthly Patent Applications.png

Technology Areas

File:Andrew Schieber of Laguna Niguel CA (US) Top Technology Areas.png

List of Technology Areas

  • A61F9/0008 ({Introducing ophthalmic products into the ocular cavity or retaining products therein (putting in contact lenses): 1 patents
  • A61K9/0051 (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations): 1 patents
  • A61K45/00 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents

Companies

File:Andrew Schieber of Laguna Niguel CA (US) Top Companies.png

List of Companies

  • The Regents of the University of Colorado, a body Corporate: 1 patents

Collaborators

Subcategories

This category has the following 3 subcategories, out of 3 total.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.